Mylan Announces Settlement Agreement for its First-to-File Generic Version of …The Herald | HeraldOnline.comPITTSBURGH, Oct. 9, 2012 — /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) today announced that it has entered into a settlement agreement with Shi…
Hindu Business LineTacrolimus manufacture: Transgene in talks with European firm for out-licensingHindu Business LineWhile refusing to name the European firm, the Hyderabad-based company's Chairman and Managing Director, K. Koteswara Rao, told news…
Horse safety is first step in racing revampLegislative GazetteIn order to reduce a trainer's incentive to enter an under-qualified horse, the report states the purse-to-claim ratio will not be allowed to exceed 1.6-to-1 and claimants will be notifi…
OncLiveBreast Oncologists Incorporate New Treatments, Grapple With Ongoing …OncLiveEverolimus, recently approved in estrogen receptor [ER]-positive metastatic breast cancer, is being tested in combination with trastuzumab in HER2-positive disease in …
FDA Approves Humira to Treat Ulcerative ColitisBecker’s ASC ReviewHumira is approved to control ulcerative colitis when immunosuppressant medicines like corticosteroids, azathioprine and 6-mercaptopurine have not worked. The drug is an anti-tumor necro…
OncLiveEverolimus Plus Tamoxifen Delivers Benefits in Hormone-Resistant mBCOncLiveCombining tamoxifen with everolimus (Afinitor) increased the clinical benefit rate (CBR), time to progression (TTP), and overall survival versus tamoxifen alone in postme…
XOMA's CEO Discusses Safety and Efficacy Study of Gevokizumab in Patients …Seeking AlphaThe most resounding message we've heard from our conversations with physicians during our planning phase has been given a drug that lets us get our patien…
Tuberous sclerosis complex lesions respond well to everolimus in EXISTNews-Medical.netSergiusz Jóźwiak (The Children's Memorial Health Institute of Warsaw, Poland) presented the results of EXamining everolimus In a Study of TSC (EXIST) 1 and 2 at…
Questcor: What's Really Changed?Seeking AlphaAccording to its FDA labeling for multiple sclerosis (MS) relapses, corticosteroids are front-line therapy for acute exacerbations of MS. Acthar is used for those patients who cannot tolerate the side ef…
International consensus group introduces recommendations, treatment …pharmabiz.comTopical therapies, especially controlled therapy with combinations of topical corticosteroids and anaesthetics are the cornerstone of achieving symptomatic relief of ha…